Paydirt
ASMB
Ticker

Assembly Biosciences, Inc.

ASMB · Healthcare · Assembly Biosciences, Inc., a biotechnology company, develops therapeutic candidates for the treatment of viral diseases worldwide

Assembly Biosciences, Inc. (ASMB), in the Healthcare sector, has 1 disclosed filing on Paydirt over the trailing twelve months from 1 corporate insider: 0 purchases and 1 sale. Filers took a median of 1 day from execution to disclosure, and the most recent trade was executed Nov 2 and filed Nov 3. The most active filer was Jason A Okazaki with 1 filing. Data as of Nov 8 2026.

Add to watchlist
Filings, ttm
1
0 buys · 1 sell
Traders, ttm
1
1 insider
Volume, ttmiDollar value disclosed in the window
$120K
estimated for Congress, as filed for insiders
Median delay
1d
execution to disclosure
Last traded
Nov 2
Filed Nov 3
ADViAverage daily dollar volume
$5.8M
market data
Share price · 12M
$20.42 (-36.3%)
$38.50$29.01$19.51Nov 10 2025May 12Nov 6

Adjusted for splits and dividends.

Volume by month
$55.0M$27.5M$0Dec 2024Jun 2025Dec 2025Jun 2026Dec 2024 · buys $20.1MOct 2025 · buys $55.0MNov 2026 · sells $120K
Buys $75.1M Sells $120K

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed · past 24 months
GI Gilead Sciences, Inc. 10% owner 2 filings · 2 buys, 0 sales JO Jason A Okazaki CEO and President 1 filing · 0 buys, 1 sale AS Alexander Schornstein 10% owner 1 filing · 1 buy, 0 sales
Recent filings
Jason A OkazakiSALE CEO and President $120K
6,133 sh × $19.61
Exec Nov 2
Filed Nov 3 · 4:30 PM ET Gilead Sciences, Inc.PURCHASE 10% owner $55.0M
as filed
Exec Aug 8 2025
Filed Oct 3 2025 · 4:30 PM ET † Gilead Sciences, Inc.PURCHASE 10% owner $20.1M
940,499 sh × $21.37
Exec Dec 19 2024
Filed Dec 23 2024 · 5:30 PM ET Alexander SchornsteinPURCHASE 10% owner $253K
17,024 sh × $14.87
Exec Nov 22 2024
Filed Nov 26 2024 · 5:30 PM ET